Trial Profile
A Randomized Controlled Trial to Determine if Sitagliptin Will Enhance Islet Graft Function When Given for 1 Year Following Transplantation
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 10 May 2022
Price :
$35
*
At a glance
- Drugs Sitagliptin (Primary)
- Indications Type 1 diabetes mellitus
- Focus Pharmacodynamics
- 27 Oct 2017 Status changed from recruiting to discontinued.
- 23 Jun 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 23 Jun 2010 Actual initiation date (Jul 2009) added as reported by ClinicalTrials.gov.